Dr. Antonia on Investigational Immunotherapy Combinations in Stage III NSCLC
June 21st 2019Scott J. Antonia, MD, PhD, instructor, Duke University School of Medicine, member, Duke Cancer Institute, discusses investigational immunotherapy combinations in stage III non–small cell lung cancer (NSCLC).
Read More